About Us
Who We Are
What We Do
What We Offer
Drug Discovery
Biotherapeutic Development
Senior Scientists
Scientific Advisory Board
Case Studies
Pipeline
Strategic Alliances
Development Funding
Agents In Clinical Development
Institutes & Charities
Start-up Companies
2006
2005
2004
2003
2002
2001
2000
Press Releases 2004
16 December 2004 Allos Therapeutics Licenses New Cancer Compound
6 December 2004 Sareum Announces Collaboration with Cancer Research Technology Limited 1 December 2004 Cancer Research Technology grants AstraZeneca an exclusive license to a key patent in the field of nuclear receptors 2 November 2004 Marie Curie Cancer Care and Cancer Research Technology extend relationship for cancer patient benefit 12 October 2004 Medical Solutions PLC and Cancer Research Technology to develop a novel toolkit for cancer drug development 29 September 2004 Cancer Research Technology and The Institute of Cancer Research complete licence with Vernalis 12 August 2004 Pharminox Ltd signs second exclusive agreement with Cancer Research Technology. - Option to license a cancer chemotherapeutic in Phase 1 clinical trials - 11 August 2004 The Institute of Cancer Research and Cancer Research Technology Make European BRCA2 Gene Patent Freely Available 20 July 2004 Cancer Research Technology grants exclusive license to Genentech to patent portfolio of an oncology target 28 June 2004 KuDOS Pharmaceuticals signs agreements with University of Cambridge and Cancer Research Technology 25 May 2004 Scancell Secures Exclusive Worldwide Licence Agreement with Cancer Research Technology for two Novel Cancer Vaccines 19 May 2004 BTG Takes Exclusive Licence to New Class of Cancer Drug from Cancer Research Technology and The Institute of Cancer Research 22 March 2004 Astex, The Wellcome Trust, The Institute of Cancer Research and Cancer Research Technology announce major cancer drug discovery collaboration 11 February 2004 Charity To Make Breast Cancer (BRCA2) Gene Freely Available Across Europe
